Adipose-Derived Stem Cell Market: What Patients Need to Know in 2026
The adipose-derived stem cell market is one of the fastest-growing areas in regenerative medicine, with more than four hundred active clinical trials, the FDA’s first-ever mesenchymal stem cell product approval in December 2024, and a growing number of patients who are choosing to bank their own fat-derived stem cells now, before the next wave of […]
The Adipose Derived Stem Cell Market: Size, Growth, and What It Means for Providers in 2026
The global adipose derived stem cell market is one of the fastest-growing segments in regenerative medicine, driven by a clinical trial pipeline exceeding four hundred active studies, the December 2024 FDA approval of the first mesenchymal stem cell product, and growing demand from patients who are proactively preserving their own cells before the next wave […]
How L2 Bio Processes and Stores Your Patients’ Cells: What Providers Need to Know
After the harvest, every step involving the patient’s tissue happens at L2 Bio’s US-based, FDA-compliant laboratory. L2 Bio receives the specimen, isolates and processes the adipose-derived stem cells, performs viability testing, cryopreserves the cells into a documented vial inventory, and manages long-term liquid nitrogen storage under current Good Tissue Practice regulations. The provider’s role ends […]
What Training Do Providers Need Before Performing Adipose Tissue Banking?
Save My Fat provides comprehensive onboarding to every partner provider before they see their first banking patient, covering the harvest procedure, patient consultation framework, informed consent requirements, chain-of-custody documentation, and specimen shipping protocol. Physicians already comfortable with minor liposuction techniques will find the procedural training familiar. Those who are not will find it achievable. No […]
The Harvest Procedure Step by Step: What Providers Actually Do
The adipose tissue harvest is a 30-minute outpatient procedure performed under local anesthesia: approximately 20 cc of subcutaneous fat collected via a small-bore cannula, packaged under chain-of-custody protocols, and shipped to L2 Bio for processing. For physicians already comfortable with minor liposuction techniques, the procedure requires minimal additional learning. For those who are not, Save […]
How to Introduce Stem Cell Banking to Patients Without Overstepping Compliance Lines
The most common reason physicians hesitate before introducing stem cell banking to patients is not skepticism about the science. It is uncertainty about what they are allowed to say. The distinction between permissible and impermissible language in this space is precise, and getting it wrong carries real professional and regulatory risk. This guide provides a […]
The First FDA-Approved Mesenchymal Stem Cell Product: What It Means for Regenerative Medicine Providers
In December 2024, the FDA approved Ryoncil (remestemcel-L-rknd), making it the first mesenchymal stem cell product to complete the full FDA approval pathway. For physicians evaluating whether the stem cell field is scientifically and regulatorily credible, this approval is the clearest available answer. It does not mean that adipose-derived cell therapies are currently approved for […]
What Your Patients Already Believe About Stem Cell Banking (And What That Means for Your Practice)
Patients asking about stem cell banking have usually done research before they ask. They have read wellness blogs, watched YouTube videos, seen clinic ads, and arrived with a mix of accurate science, reasonable conclusions, and significant misconceptions all blended together. A physician who understands what patients actually believe, and where those beliefs came from, can […]
How Stem Cell Banking Fits Into a Cash-Pay Practice Model in 2026
For physicians already working in a cash-pay or hybrid model, stem cell banking adds a compliant service line that requires no insurance billing, no new equipment, and no additional laboratory infrastructure. The harvest is a 30-minute outpatient procedure under local anesthesia. L2 Bio handles all cell processing and storage. Save My Fat routes patients in […]
The Regenerative Medicine Market in 2026: What Physicians Need to Know Before Deciding
Regenerative medicine is no longer a fringe category. The adipose-derived stem cell market is growing at a documented 15% annually, the FDA approved its first mesenchymal stem cell product at the end of 2024, and more than 400 clinical trials involving adipose-derived cells are actively recruiting worldwide. For physicians considering whether to add stem cell […]
